MGB Personalized Medicine - Laboratory for Molecular Medicine

 Please visit us at: MGB Personalized Medicine - Laboratory for Molecular Medicine

About Us

Enabling clinical adoption of personalized genetic medicine

The Laboratory for Molecular Medicine (LMM) is a CLIA-certified molecular diagnostic laboratory, operated by MGB Personalized Medicine. The LMM is led by a group of Harvard Medical School-affiliated faculty, geneticists, clinicians, and researchers from Brigham and Women’s Hospital and Massachusetts General Hospital. Our mission is to bridge the gap between research and clinical medicine by remaining focused on the following:

-Leading the implementation of advanced technologies and practices into molecular diagnostic testing;

-Accelerating the adoption of new molecular tests into clinical care;

-Incorporating information technology (IT) support into the day-to-day operations of the clinical laboratory; and

-Advancing clinical care with our participation in innovative programs, aiming to keep physicians current on and knowledgeable of genetic information relevant to their patients.

Through this work, the LMM is taking the promise of personalized medicine from the lab and into the clinic. Each year, we provide services to more than 4,000 patients and their physicians offering testing of genome and exome sequencing, targeted gene panels and polygenic risk assays. We are working with clinical researchers and physicians to make a difference in the lives of patients.

Comprehensive testing services

We offer comprehensive testing services to support clinical research and clinical practice. Working with LMM, you and your team will have access to:

-A wide range of tests, including single gene, multiple gene panel, genome sequencing and now polygenic risk tests for cardiovascular conditions.

  • Tests are offered in the following areas:
    • Genome Sequencing
    • Hearing Loss
    • OtoGenome Test™ for hearing loss and related syndrome (110 genes) 
    • Connexin test: GJB2 sequencing and DFNB1 (GJB6) deletion
    • SLC26A4 (PDS) gene test
    • WFS1 gene sequencing test
    • POU3F4 gene test
    • Kidney disease
    • Cardiomyopathy tests
    • PanCardiomyopathy Panel (62 Genes) Test
    • TTR gene sequencing test
    • Polygenic Risk

-Prominent clinical molecular geneticists, researchers, physicians and genetic counselors within the Harvard Medical School and Mass General Brigham system;

-GeneInsight Suite®, an advanced system that streamlines the interpretation and management of genetic data and knowledge. The system is capable of generating real time alerts to clinicians when the LMM changes classification of variants previously identified in one or more of their patients; and

-Comprehensive, accurate, evidence-based, personalized reports that are clinically meaningful.

For a test menu, please click here: LMM Test Menu

For prices and CPT codes, please click here:  LMM Prices and CPT Codes